Fingolimod granted FDA Breakthrough Therapy designation for paediatric MS
Novartis today announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for fingolimod for the treatment of children and adolescents 10 years of age or older with relapsing multiple sclerosis (MS)...Read more - http://www.ms-uk.org/fingolimod-granted ... diatric-ms
Fingolimod granted FDA Breakthrough Therapy designation...
Fingolimod granted FDA Breakthrough Therapy designation...
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 2355 Views
-
Last post by frodo
-
- 0 Replies
- 12165 Views
-
Last post by NHE
-
- 0 Replies
- 199 Views
-
Last post by tzootsi
-
- 2 Replies
- 1732 Views
-
Last post by jimmylegs
-
- 0 Replies
- 1307 Views
-
Last post by NHE
-
- 2 Replies
- 1988 Views
-
Last post by frodo
-
- 0 Replies
- 12700 Views
-
Last post by NHE
-
- 0 Replies
- 2695 Views
-
Last post by frodo
-
- 0 Replies
- 2884 Views
-
Last post by NHE